Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Verisante Technology Inc V.VER.H

Alternate Symbol(s):  VRSEF

Verisante Technology, Inc. is a Canada-based company. The Company does not operate any active business other than to identify and complete a reverse takeover (RTO) with a company in one of its target sectors that demonstrates significant growth potential and/or value creation opportunities for shareholders. The Company may pursue a target in any industry, it intends to focus its search on companies that meet its acquisition target characteristics within the life sciences sectors.


TSXV:VER.H - Post by User

Bullboard Posts
Post by electricsocketson Jul 01, 2013 7:28pm
78 Views
Post# 21583296

who is bo-pharma anyway?

who is bo-pharma anyway?this link to a recent slide show may give / offer you some perpective....nice to see verisante mentioned. 

https://www.slideshare.net/HPOONK/company-pres-online

In addition, from VRS's Jan'13 PR's as a friendly reminder: 

"And Dr. Henk-Peter Oonk, CEO of bo pharma BV is confident that Aura™ will be very well received in the Benelux region, where traditionally new technologies are adopted quickly. "Recent expansion of our exclusive distribution agreement for Aura™ to include the Nordic countries in addition to the Benelux region underlines our confidence in this product and this technology as we prepare for product launch." "

also: 


“Aura™ is a game-changing device in the field of skin cancer diagnosis,” said Dr. Henk-Peter Oonk, CEO of bo pharma. “We anticipate significant demand of this new technology in Benelux and welcome the opportunity to widen this adoption into the Nordic countries, where bo pharma has rapid expansion plans.”

end quote 

Here's hoping that Q2 will help validate these recent statements ;) 

good luck to the longs. 
Bullboard Posts